Astrazeneca Pharma India

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue236.44242.92257.01292.70303.56
Expenses209.15198.85217.55229.19232.16
EBITDA32.0847.5243.7867.8575.35
EBIT27.4944.2339.6623.3771.55
Profit Before Tax27.3044.0739.4523.2871.40
Net Profit20.1532.5629.3017.2753.86
Financial Ratios
Operating Profit Margin13.81%20.12%17.53%9.70%25.50%
Net Profit Margin8.67%13.79%11.73%17.25%18.23%
Earning Per Share (Diluted)8.0613.0311.726.9121.54
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ